ADPT

ADPT Operating Cash Flow (Statement)

-$21.01MTTM · USD

Period ending:

ADPT FY Cash from OperationsUSD
ADPT FY Cash from Operations2017-12-31: -$34.86M2018-12-31: -$32.26M2019-12-31: $205.40M2020-12-31: -$149.68M2021-12-31: -$192.73M2022-12-31: -$183.95M2023-12-31: -$156.32M2024-12-31: -$95.21M2025-12-31: -$45.99M$205.40M-$192.73M
2017-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ADPT operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 9 observations from Dec 31, 2017 to Dec 31, 2025.

Adaptive Biotechnologies Corp Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-45,986,000
-95,212,000
-156,324,000
-183,945,000
-192,727,000
-149,683,000
205,404,000
-32,259,000
-34,858,000

Compare operating cash flow (statement)

All ADPT financial metrics · ADPT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.